2014
DOI: 10.1177/1721727x1401200115
|View full text |Cite
|
Sign up to set email alerts
|

Reciprocal Action of Pentraxin-3 and CRP in Women with Polycystic Ovary Syndrome

Abstract: The aim of this study was to investigate the relationship between pentraxin-3 and other biochemical parameters in women with polycystic ovary syndrome (PCOS). We compared 58 women with PCOS to 34 body mass index- and age-matched normally menstruating healthy controls. Women with PCOS had significantly higher DHEA-S, free testosterone, LH and FAI, but lower pentraxin-3 levels when compared to healthy controls (0.86±0.21 and 0.91±0.14 respectively, p=0.014). Levels of CRP and lipoprotein-a were higher in the PCO… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 29 publications
(28 reference statements)
0
5
0
Order By: Relevance
“…The remaining 25 studies failed to demonstrate any statistically significant difference in serum CRP levels between PCOS women and healthy controls. Of these, seven studies reported statistically significant increase in other inflammatory markers as described below [ 49 , 50 , 59 , 67 , 69 , 85 , 86 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The remaining 25 studies failed to demonstrate any statistically significant difference in serum CRP levels between PCOS women and healthy controls. Of these, seven studies reported statistically significant increase in other inflammatory markers as described below [ 49 , 50 , 59 , 67 , 69 , 85 , 86 ].…”
Section: Resultsmentioning
confidence: 99%
“…In addition to the increased inflammatory markers, our review has found reduced adiponectin, which is a well-known anti-inflammatory factor, in PCOS women. Some studies have also reported a decrease in Pentraxin -3 (PTX3) [ 30 , 86 ], which is structurally related to CRP and plays a regulatory role in inflammation with a possible protective effect against atherosclerosis and cardiovascular risks [ 127 ]. All these findings indicate that the ongoing inflammation in PCOS is a double-sided process with increased proinflammatory factors as well as reduced inflammatory protective factors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The follicular PTX3 level among non-obese women was significantly higher in PCOS subjects and associated with the existence of PCOS and ovarian hyperandrogenism [18]. However, circulating PTX3 in PCOS women was previously reported as elevated [22,23], diminished [24,25], or similar [32] to non-PCOS subjects. Recently, researchers from Helsinki found that circulating PTX3 levels during in vitro fertilization could provide benefits in risk assessment for ovarian hyperstimulation syndrome [33].…”
Section: Discussionmentioning
confidence: 89%
“…Up to now, there were several studies investigating serum PTX3 level in PCOS, but the association between PTX3 and PCOS remains uncertain. Among these studies, serum PTX3 level in PCOS women was found to be lower [ 12 , 13 ], higher [ 14 , 17 ], or comparable [ 18 ] to that of non-PCOS women. In contrast to the short pentraxin, CRP, which is predominantly produced in the liver, PTX3 is synthesized in response to local inflammatory stimuli by a variety of cells, and ovarian follicular cells have innate immune capabilities that modulate their endocrine function [ 19 ].…”
Section: Discussionmentioning
confidence: 99%